Reply

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 6, 2010, Pages 1413-1414

  Waibel, Kirk H ^a   Gomez, Robert ^b  

^a BROOKE ARMY MEDICAL CENTER   (United States)

^b WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; OVALBUMIN;

DRUG SAFETY; EGG ALLERGY; HUMAN; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; LETTER; PRIORITY JOURNAL; SINGLE DRUG DOSE;

EID: 77952745776     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.03.011     Document Type: Letter

References (3)

1. Li J.T., Rank M.A., Squillace D.L., and Kita H. Ovalbumin content of influenza vaccines. J Allergy Clin Immunol 125 (2010) 1412-1413
2. Esposito S., Gasparini C., Martelli A., Zenga A., Tremolati E., Varin E., et al. Safe administration of an inactivated virosomal adjuvanted influenza vaccine in asthmatic children with egg allergy. Vaccine 26 (2008) 4664-4668
3. Waibel K.H., and Gomez R. Ovalbumin content in 2009 to 2010 seasonal and H1N1 monovalent influenza vaccines. J Allergy Clin Immunol (2010 Jan 7) [epub ahead of print]